 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1873 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
60: Requires occasional assistance but is able to care for most of own needs |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Not Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
03/04/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy |
 |
 |
 |
 |
Contact: |
 |
Philip J. Bierman MD U. of Nebraska Medical Center Contact: Rose K. Solberg, RN, BSN, CCRC
Omaha, NE 68198 USA Phone: 402-559-4810 Fax: E-mail: rsolberg@unmc.edu Website: |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|